HCPCS Level II
J1551
Injection, immune globulin (cutaquig), 100 mg
Codes near J1551
These sit next to J1551 in the CMS Level II file. All J codes
- J1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
- J1457Injection, gallium nitrate, 1 mg
- J1458Injection, galsulfase, 1 mg
- J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1460Injection, gamma globulin, intramuscular, 1 cc
- J1552Injection, immune globulin (alyglo), 500 mg
- J1553Injection, immune globulin (yimmugo), 100 mg
- J1554Injection, immune globulin (asceniv), 500 mg
- J1555Injection, immune globulin (cuvitru), 100 mg
- J1556Injection, immune globulin (bivigam), 500 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00069-1061-02 | Cutaquig | Pfizer Inc | 10 |
| 00069-1476-02 | Cutaquig | Pfizer Inc | 20 |
| 00069-1509-02 | Cutaquig | Pfizer Inc | 40 |
| 00069-1965-02 | Cutaquig | Pfizer Inc | 80 |
| 68982-0810-01 | Cutaquig | Octapharma USA Inc. | 10 |
| 68982-0810-03 | Cutaquig | Octapharma USA Inc. | 20 |
| 68982-0810-04 | Cutaquig | Octapharma USA Inc. | 33 |
| 68982-0810-05 | Cutaquig | Octapharma USA Inc. | 40 |
| 68982-0810-06 | Cutaquig | Octapharma USA Inc. | 80 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.